A 12 Week, Multi-Center,Randomized, Double Blinded, Parallel Group, Placebo-Controlled, 4-Arm, Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma.

Trial Profile

A 12 Week, Multi-Center,Randomized, Double Blinded, Parallel Group, Placebo-Controlled, 4-Arm, Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Dec 2013

At a glance

  • Drugs SOTB 07 (Primary) ; Montelukast
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Mar 2011 Planned end date changed from 1 Mar 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.
    • 23 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 18 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top